237690.KQ
ST Pharm Co.,Ltd.
KOE · Healthcare · Medical - Pharmaceuticals · KR
KRW 99,000.00
−2.17%Year over year
Reported trailing growth
- Revenue
- +29.6%
- EBITDA
- +25.4%
- EBIT
- +64.9%
- EPS
- +116.2%
- Free cash flow
- +1035.5%
- Operating cash flow
- +61.2%
Forward estimates
Based on analyst estimates
- Revenue
- +26.9%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +10.0%
- EBITDA
- +28.6%
- EBIT
- +45.1%
- Net income
- +45.1%
- EPS
- +41.4%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026